Free Trial
→ Iran's New Leader Just Said Something That Should Terrify Every American (From American Alternative) (Ad)tc pixel Free UTRS Stock Alerts

Minerva Surgical (UTRS) Competitors

Minerva Surgical logo
Compare

UTRS vs. MOTS, DRTSW, ANZUW, HSCSW, and BEATW

Should you be buying Minerva Surgical stock or one of its competitors? The main competitors of Minerva Surgical include Motus GI (MOTS), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Heart Test Laboratories (HSCSW), and HeartBeam (BEATW). These companies are all part of the "medical equipment" industry.

How does Minerva Surgical compare to Motus GI?

Minerva Surgical (NASDAQ:UTRS) and Motus GI (NASDAQ:MOTS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, media sentiment, valuation, earnings, institutional ownership and dividends.

Minerva Surgical has a beta of 2.92, meaning that its share price is 192% more volatile than the S&P 500. Comparatively, Motus GI has a beta of 0.87, meaning that its share price is 13% less volatile than the S&P 500.

In the previous week, Minerva Surgical had 1 more articles in the media than Motus GI. MarketBeat recorded 1 mentions for Minerva Surgical and 0 mentions for Motus GI. Minerva Surgical's average media sentiment score of 0.00 equaled Motus GI'saverage media sentiment score.

Company Overall Sentiment
Minerva Surgical Neutral
Motus GI Neutral

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
Motus GI N/A N/A N/A

20.1% of Motus GI shares are held by institutional investors. 8.5% of Minerva Surgical shares are held by insiders. Comparatively, 0.3% of Motus GI shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Motus GI has lower revenue, but higher earnings than Minerva Surgical. Motus GI is trading at a lower price-to-earnings ratio than Minerva Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A
Motus GI$319K0.00-$12.87M-$14.69N/A

Summary

Minerva Surgical beats Motus GI on 5 of the 8 factors compared between the two stocks.

How does Minerva Surgical compare to Alpha Tau Medical?

Minerva Surgical (NASDAQ:UTRS) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, profitability, media sentiment, institutional ownership and earnings.

In the previous week, Minerva Surgical had 1 more articles in the media than Alpha Tau Medical. MarketBeat recorded 1 mentions for Minerva Surgical and 0 mentions for Alpha Tau Medical. Minerva Surgical's average media sentiment score of 0.00 equaled Alpha Tau Medical'saverage media sentiment score.

Company Overall Sentiment
Minerva Surgical Neutral
Alpha Tau Medical Neutral

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
Alpha Tau Medical N/A N/A N/A

Alpha Tau Medical has lower revenue, but higher earnings than Minerva Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

Summary

Minerva Surgical beats Alpha Tau Medical on 2 of the 2 factors compared between the two stocks.

How does Minerva Surgical compare to Anzu Special Acquisition Corp I?

Minerva Surgical (NASDAQ:UTRS) and Anzu Special Acquisition Corp I (NASDAQ:ANZUW) are both medical equipment companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, profitability, media sentiment, institutional ownership and earnings.

In the previous week, Minerva Surgical had 1 more articles in the media than Anzu Special Acquisition Corp I. MarketBeat recorded 1 mentions for Minerva Surgical and 0 mentions for Anzu Special Acquisition Corp I. Minerva Surgical's average media sentiment score of 0.00 equaled Anzu Special Acquisition Corp I'saverage media sentiment score.

Company Overall Sentiment
Minerva Surgical Neutral
Anzu Special Acquisition Corp I Neutral

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
Anzu Special Acquisition Corp I N/A N/A N/A

Anzu Special Acquisition Corp I has lower revenue, but higher earnings than Minerva Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A
Anzu Special Acquisition Corp IN/AN/AN/AN/AN/A

Summary

Minerva Surgical beats Anzu Special Acquisition Corp I on 2 of the 2 factors compared between the two stocks.

How does Minerva Surgical compare to Heart Test Laboratories?

Heart Test Laboratories (NASDAQ:HSCSW) and Minerva Surgical (NASDAQ:UTRS) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, media sentiment, dividends, valuation and profitability.

Company Net Margins Return on Equity Return on Assets
Heart Test LaboratoriesN/A N/A N/A
Minerva Surgical N/A N/A N/A

Heart Test Laboratories has higher earnings, but lower revenue than Minerva Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Heart Test Laboratories$8.67KN/AN/AN/AN/A
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A

In the previous week, Minerva Surgical had 1 more articles in the media than Heart Test Laboratories. MarketBeat recorded 1 mentions for Minerva Surgical and 0 mentions for Heart Test Laboratories. Heart Test Laboratories' average media sentiment score of 0.00 equaled Minerva Surgical'saverage media sentiment score.

Company Overall Sentiment
Heart Test Laboratories Neutral
Minerva Surgical Neutral

Summary

Minerva Surgical beats Heart Test Laboratories on 2 of the 2 factors compared between the two stocks.

How does Minerva Surgical compare to HeartBeam?

HeartBeam (NASDAQ:BEATW) and Minerva Surgical (NASDAQ:UTRS) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, media sentiment, dividends, valuation and profitability.

Company Net Margins Return on Equity Return on Assets
HeartBeamN/A N/A N/A
Minerva Surgical N/A N/A N/A

HeartBeam has higher earnings, but lower revenue than Minerva Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HeartBeamN/AN/AN/AN/AN/A
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A

In the previous week, Minerva Surgical had 1 more articles in the media than HeartBeam. MarketBeat recorded 1 mentions for Minerva Surgical and 0 mentions for HeartBeam. HeartBeam's average media sentiment score of 0.00 equaled Minerva Surgical'saverage media sentiment score.

Company Overall Sentiment
HeartBeam Neutral
Minerva Surgical Neutral

Summary

Minerva Surgical beats HeartBeam on 2 of the 2 factors compared between the two stocks.

Get Minerva Surgical News Delivered to You Automatically

Sign up to receive the latest news and ratings for UTRS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UTRS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UTRS vs. The Competition

Export
MetricMinerva SurgicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$1K$46.11M$6.25B$11.87B
Dividend YieldN/A1.08%2.73%5.21%
P/E Ratio0.0018.5829.0428.48
Price / SalesN/A30.72476.4860.89
Price / CashN/A18.8827.6236.52
Price / BookN/A14.279.676.67
Net Income-$34.11M-$20.10M$3.55B$332.64M

Minerva Surgical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
UTRS
Minerva Surgical
N/AN/AN/AN/A$1K$51.69MN/A160
MOTS
Motus GI
N/AN/AN/AN/A$1K$319KN/A30
DRTSW
Alpha Tau Medical
N/A$1.14
-14.2%		N/AN/A$0.00N/AN/A80
ANZUW
Anzu Special Acquisition Corp I
N/A$0.07
+8.1%		N/AN/A$0.00N/AN/A2
HSCSW
Heart Test Laboratories
N/A$0.09
+36.4%		N/AN/A$0.00$8.67KN/A10

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:UTRS) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
The $1.75T "Backdoor" ticker (NOT Starlink)
When the SpaceX IPO launches, most investors will already be too late. The real opportunity isn't the IPO itse...
Behind the Markets | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel